Ardelyx
ARDX4.8700.81% ( -0.040 )
Ardelyx (ARDX)
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSREL...
- Open
- 4.890
- High
- 5.000
- Low
- 4.815
- Prev. Close
- 4.910
- Volume
- 7.28M
- Turnover
- 33.45M
- Avg Price
- 4.593
- Bid/Ask Ratio
- --
- Amplitude
- 3.77%
- 52wk High
- 8.400
- Volume Ratio
- 2.77
- Turnover Ratio
- 3.31%
Ardelyx Analyst Rating
View MoreForecast & Rating
Aug 5, 2026Price forecast
$16.30234.70%
Forecast & RatingStrong buy
11analysts
- Strong buy90.91%
- Buy9.09%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 2 hours ago
12 Health Care Stocks Moving In Thursday's After-Market Session
- Earnings Watch · 3 hours ago
Ardelyx | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 120.88 M
- StockTitan · Jul 22 at 11:01 PM
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026 | ARDX Stock News
- PUBT · Jul 17 at 03:09 PM
Ardelyx CEO Michael Raab disposes of 41,668 common shares worth $210,884.22
- Tip Ranks · Jul 13 at 09:45 AM
Ardelyx (ARDX) Receives a Buy from Wedbush
- PUBT · Jul 2 at 04:02 PM
Ardelyx draws USD 50 million Term F loan under amended SLR Investment credit agreement
